ID   KSYK_RAT                Reviewed;         629 AA.
AC   Q64725;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 197.
DE   RecName: Full=Tyrosine-protein kinase SYK;
DE            EC=2.7.10.2;
DE   AltName: Full=Spleen tyrosine kinase;
DE   AltName: Full=p72Syk;
GN   Name=Syk;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING (ISOFORMS SYKA AND
RP   SYKB).
RX   PubMed=7759516; DOI=10.1074/jbc.270.21.12659;
RA   Rowley R.B., Bolen J.B., Fargnoli J.;
RT   "Molecular cloning of rodent p72Syk. Evidence of alternative mRNA
RT   splicing.";
RL   J. Biol. Chem. 270:12659-12664(1995).
RN   [2]
RP   FUNCTION IN PHOSPHORYLATION OF HCLS1.
RX   PubMed=8611520; DOI=10.1021/bi9528614;
RA   Ruzzene M., Brunati A.M., Marin O., Donella-Deana A., Pinna L.A.;
RT   "SH2 domains mediate the sequential phosphorylation of HS1 protein by
RT   p72syk and Src-related protein tyrosine kinases.";
RL   Biochemistry 35:5327-5332(1996).
RN   [3]
RP   PHOSPHORYLATION AT TYR-317 BY LYN, AND PHOSPHORYLATION AT TYR-342 AND
RP   TYR-346.
RX   PubMed=12077122; DOI=10.1074/jbc.m201362200;
RA   Hong J.J., Yankee T.M., Harrison M.L., Geahlen R.L.;
RT   "Regulation of signaling in B cells through the phosphorylation of Syk on
RT   linker region tyrosines. A mechanism for negative signaling by the Lyn
RT   tyrosine kinase.";
RL   J. Biol. Chem. 277:31703-31714(2002).
CC   -!- FUNCTION: Non-receptor tyrosine kinase which mediates signal
CC       transduction downstream of a variety of transmembrane receptors
CC       including classical immunoreceptors like the B-cell receptor (BCR).
CC       Regulates several biological processes including innate and adaptive
CC       immunity, cell adhesion, osteoclast maturation, platelet activation and
CC       vascular development. Assembles into signaling complexes with activated
CC       receptors at the plasma membrane via interaction between its SH2
CC       domains and the receptor tyrosine-phosphorylated ITAM domains. The
CC       association with the receptor can also be indirect and mediated by
CC       adapter proteins containing ITAM or partial hemITAM domains. The
CC       phosphorylation of the ITAM domains is generally mediated by SRC
CC       subfamily kinases upon engagement of the receptor. More rarely signal
CC       transduction via SYK could be ITAM-independent. Direct downstream
CC       effectors phosphorylated by SYK include DEPTOR, VAV1, PLCG1, PI-3-
CC       kinase, LCP2 and BLNK. Initially identified as essential in B-cell
CC       receptor (BCR) signaling, it is necessary for the maturation of B-cells
CC       most probably at the pro-B to pre-B transition. Activated upon BCR
CC       engagement, it phosphorylates and activates BLNK an adapter linking the
CC       activated BCR to downstream signaling adapters and effectors. It also
CC       phosphorylates and activates PLCG1 and the PKC signaling pathway. It
CC       also phosphorylates BTK and regulates its activity in B-cell antigen
CC       receptor (BCR)-coupled signaling. In addition to its function
CC       downstream of BCR also plays a role in T-cell receptor signaling. Plays
CC       also a crucial role in the innate immune response to fungal, bacterial
CC       and viral pathogens. It is for instance activated by the membrane
CC       lectin CLEC7A. Upon stimulation by fungal proteins, CLEC7A together
CC       with SYK activates immune cells inducing the production of ROS. Also
CC       activates the inflammasome and NF-kappa-B-mediated transcription of
CC       chemokines and cytokines in presence of pathogens. Regulates neutrophil
CC       degranulation and phagocytosis through activation of the MAPK signaling
CC       cascade. Required for the stimulation of neutrophil phagocytosis by
CC       IL15 (By similarity). Also mediates the activation of dendritic cells
CC       by cell necrosis stimuli. Also involved in mast cells activation.
CC       Involved in interleukin-3/IL3-mediated signaling pathway in basophils
CC       (By similarity). Also functions downstream of receptors mediating cell
CC       adhesion. Relays for instance, integrin-mediated neutrophils and
CC       macrophages activation and P-selectin receptor/SELPG-mediated
CC       recruitment of leukocytes to inflammatory loci. Also plays a role in
CC       non-immune processes. It is for instance involved in vascular
CC       development where it may regulate blood and lymphatic vascular
CC       separation. It is also required for osteoclast development and
CC       function. Functions in the activation of platelets by collagen,
CC       mediating PLCG2 phosphorylation and activation. May be coupled to the
CC       collagen receptor by the ITAM domain-containing FCER1G. Also activated
CC       by the membrane lectin CLEC1B that is required for activation of
CC       platelets by PDPN/podoplanin. Involved in platelet adhesion being
CC       activated by ITGB3 engaged by fibrinogen. Together with CEACAM20,
CC       enhances production of the cytokine CXCL8/IL-8 via the NFKB pathway and
CC       may thus have a role in the intestinal immune response (By similarity).
CC       {ECO:0000250|UniProtKB:P43405, ECO:0000250|UniProtKB:P48025,
CC       ECO:0000269|PubMed:8611520}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Autoinhibited. Intramolecular binding of the
CC       interdomains A and B (also called linker region) to parts of the
CC       catalytic domain keep the catalytic center in an inactive conformation.
CC       The phosphorylation of the interdomains or the binding of the SH2
CC       domains with dually phosphorylated ITAM domains on transmembrane
CC       proteins disrupt those intramolecular interactions allowing the kinase
CC       domain to adopt an active conformation. The phosphorylation of SYK and
CC       of the ITAM domains which is responsible for SYK activation is
CC       essentially mediated by SRC subfamily kinases, like LYN, upon
CC       transmembrane receptors engagement. May also be negatively regulated by
CC       PTPN6 through dephosphorylation. Downstream signaling adapters and
CC       intermediates like BLNK or RHOH may mediate positive and/or negative
CC       feedback regulation. Negatively regulated by CBL and CBLB through
CC       ubiquitination and probable degradation (By similarity). Phosphorylates
CC       SH3BP2 which in turn may regulate SYK through LYN (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with LYN; phosphorylates SYK. Interacts with RHOH
CC       (phosphorylated); regulates mast cells activation. Interacts with NFAM1
CC       (phosphorylated); probably involved in BCR signaling. Interacts with
CC       VAV1 (via SH2 domain); phosphorylates VAV1 upon BCR activation.
CC       Interacts with GAB2 (phosphorylated); probably involved in IgE Fc
CC       receptor signaling. Interacts (via its SH2 domains) with CD79A (via its
CC       phosphorylated ITAM domain); the interaction stimulates SYK
CC       autophosphorylation and activation. Interacts (via SH2 domains) with
CC       FCER1G (via ITAM domain); activates SYK and mediates neutrophils and
CC       macrophages integrin-mediated activation. Interaction with FCER1G in
CC       basophils triggers IL3-induced IL4 production (By similarity).
CC       Interacts with ITGB2 and FGR; involved in ITGB2 downstream signaling.
CC       Interacts with ITGB3; upon activation by ITGB3 promotes platelet
CC       adhesion. Interacts (via SH2 domains) with TYROBP (via ITAM domain);
CC       involved in neutrophils and macrophages integrin-mediated activation.
CC       Interacts with MSN and SELPLG; mediates the selectin-dependent
CC       activation of SYK by SELPLG. Interacts with BLNK (via SH2 domain).
CC       Interacts (via the second SH2 domain) with USP25 (via C-terminus);
CC       phosphorylates USP25 and regulates USP25 intracellular levels.
CC       Interacts (via SH2 domains) with CLEC1B (dimer). Interacts with CLEC7A;
CC       participates in leukocyte activation in presence of fungal pathogens.
CC       Interacts (phosphorylated) with SLA; may regulate SYK through CBL
CC       recruitment. Interacts with YWHAG; attenuates BCR-induced membrane
CC       translocation and activation of SYK (By similarity). Interacts (via SH2
CC       domains) with GCSAM; the interaction increases after B-cell receptor
CC       stimulation, resulting in enhanced SYK autophosphorylation and activity
CC       (By similarity). Interacts with TNS2; leading to the phosphorylation of
CC       SYK (By similarity). Interacts with FLNA (via filamin repeat 5); docks
CC       SYK to the plasma membrane (By similarity). Interacts with CEACAM1;
CC       lipopolysaccharide activated neutrophils induce phosphorylation of SYK
CC       resulting in the formation of a complex including TLR4, phosphorylated
CC       form of SYK and CEACAM1, which in turn, recruits PTPN6 that
CC       dephosphorylates SYK, reducing the production of reactive oxygen
CC       species (ROS) and lysosome disruption, leading to a reduction of the
CC       inflammasome activity (By similarity). Interacts (via SH2 domains) with
CC       CEACAM20 (phosphorylated form); the interaction further enhances
CC       CEACAM20 phosphorylation (By similarity). Interacts with IL15RA (By
CC       similarity). {ECO:0000250|UniProtKB:P43405,
CC       ECO:0000250|UniProtKB:P48025}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}. Cytoplasm, cytosol
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=SykB;
CC         IsoId=Q64725-1; Sequence=Displayed;
CC       Name=SykA;
CC         IsoId=Q64725-2; Sequence=VSP_005011;
CC   -!- DOMAIN: The SH2 domains mediate the interaction of SYK with the
CC       phosphorylated ITAM domains of transmembrane proteins. Some proteins
CC       like CLEC1B have a partial ITAM domain (also called hemITAM) containing
CC       a single YxxL motif. The interaction with SYK requires CLEC1B
CC       homodimerization (By similarity). {ECO:0000250}.
CC   -!- PTM: Autophosphorylated. Phosphorylated on tyrosine residues by LYN
CC       following receptors engagement. Phosphorylation on Tyr-317 creates a
CC       binding site for CBL, an adapter protein that serves as a negative
CC       regulator of BCR-stimulated calcium ion signaling (By similarity).
CC       Phosphorylation at Tyr-342 creates a binding site for VAV1 (By
CC       similarity). Phosphorylation on Tyr-342 and Tyr-346 enhances the
CC       phosphorylation and activation of phospholipase C-gamma and the early
CC       phase of calcium ion mobilization via a phosphoinositide 3-kinase-
CC       independent pathway (By similarity). Phosphorylated on tyrosine
CC       residues in response to IL15 (By similarity). Phosphorylation on Ser-
CC       291 is very common, it peaks 5 minutes after BCR stimulation, and
CC       creates a binding site for YWHAG (By similarity). Phosphorylation at
CC       Tyr-624 creates a binding site for BLNK (By similarity).
CC       Dephosphorylated by PTPN6 (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P43405}.
CC   -!- PTM: Ubiquitinated by CBLB after BCR activation; which promotes
CC       proteasomal degradation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SYK/ZAP-70 subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U21684; AAA75167.1; -; mRNA.
DR   EMBL; U21683; AAA75166.1; -; mRNA.
DR   RefSeq; NP_036890.1; NM_012758.1.
DR   AlphaFoldDB; Q64725; -.
DR   SMR; Q64725; -.
DR   BioGRID; 247220; 2.
DR   IntAct; Q64725; 16.
DR   STRING; 10116.ENSRNOP00000016942; -.
DR   BindingDB; Q64725; -.
DR   ChEMBL; CHEMBL4364; -.
DR   iPTMnet; Q64725; -.
DR   PhosphoSitePlus; Q64725; -.
DR   PaxDb; 10116-ENSRNOP00000016942; -.
DR   GeneID; 25155; -.
DR   KEGG; rno:25155; -.
DR   AGR; RGD:3796; -.
DR   CTD; 6850; -.
DR   RGD; 3796; Syk.
DR   eggNOG; ENOG502QT06; Eukaryota.
DR   InParanoid; Q64725; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; Q64725; -.
DR   BRENDA; 2.7.10.2; 5301.
DR   Reactome; R-RNO-114604; GPVI-mediated activation cascade.
DR   Reactome; R-RNO-2029481; FCGR activation.
DR   Reactome; R-RNO-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-RNO-2029485; Role of phospholipids in phagocytosis.
DR   Reactome; R-RNO-2424491; DAP12 signaling.
DR   Reactome; R-RNO-2454202; Fc epsilon receptor (FCERI) signaling.
DR   Reactome; R-RNO-2730905; Role of LAT2/NTAL/LAB on calcium mobilization.
DR   Reactome; R-RNO-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-RNO-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-RNO-354192; Integrin signaling.
DR   Reactome; R-RNO-5621480; Dectin-2 family.
DR   Reactome; R-RNO-9020558; Interleukin-2 signaling.
DR   Reactome; R-RNO-912631; Regulation of signaling by CBL.
DR   Reactome; R-RNO-9674555; Signaling by CSF3 (G-CSF).
DR   Reactome; R-RNO-9705462; Inactivation of CSF3 (G-CSF) signaling.
DR   Reactome; R-RNO-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   PRO; PR:Q64725; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0019815; C:B cell receptor complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0032009; C:early phagosome; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0042101; C:T cell receptor complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; ISO:RGD.
DR   GO; GO:0005178; F:integrin binding; ISO:RGD.
DR   GO; GO:0016170; F:interleukin-15 receptor binding; ISO:RGD.
DR   GO; GO:0016301; F:kinase activity; ISO:RGD.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0019902; F:phosphatase binding; ISO:RGD.
DR   GO; GO:0043274; F:phospholipase binding; ISO:RGD.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:RGD.
DR   GO; GO:0004672; F:protein kinase activity; IDA:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; EXP:Reactome.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0035325; F:Toll-like receptor binding; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:RGD.
DR   GO; GO:0002250; P:adaptive immune response; ISS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0030183; P:B cell differentiation; ISO:RGD.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0043366; P:beta selection; ISO:RGD.
DR   GO; GO:0048514; P:blood vessel morphogenesis; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0001775; P:cell activation; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0007169; P:cell surface receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:1990858; P:cellular response to lectin; ISO:RGD.
DR   GO; GO:0071396; P:cellular response to lipid; ISO:RGD.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; ISS:UniProtKB.
DR   GO; GO:0071226; P:cellular response to molecule of fungal origin; ISS:UniProtKB.
DR   GO; GO:0038063; P:collagen-activated tyrosine kinase receptor signaling pathway; ISO:RGD.
DR   GO; GO:0042742; P:defense response to bacterium; ISS:UniProtKB.
DR   GO; GO:0007167; P:enzyme-linked receptor protein signaling pathway; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0042492; P:gamma-delta T cell differentiation; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; ISS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0038156; P:interleukin-3-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0002366; P:leukocyte activation involved in immune response; ISS:UniProtKB.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; ISS:UniProtKB.
DR   GO; GO:0019370; P:leukotriene biosynthetic process; ISO:RGD.
DR   GO; GO:0001945; P:lymph vessel development; ISS:UniProtKB.
DR   GO; GO:0002281; P:macrophage activation involved in immune response; ISS:UniProtKB.
DR   GO; GO:0043303; P:mast cell degranulation; ISO:RGD.
DR   GO; GO:0002283; P:neutrophil activation involved in immune response; ISS:UniProtKB.
DR   GO; GO:0030593; P:neutrophil chemotaxis; ISS:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0046638; P:positive regulation of alpha-beta T cell differentiation; ISO:RGD.
DR   GO; GO:0046641; P:positive regulation of alpha-beta T cell proliferation; ISO:RGD.
DR   GO; GO:0045579; P:positive regulation of B cell differentiation; ISO:RGD.
DR   GO; GO:0045780; P:positive regulation of bone resorption; ISS:UniProtKB.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0033630; P:positive regulation of cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0001819; P:positive regulation of cytokine production; ISO:RGD.
DR   GO; GO:0045588; P:positive regulation of gamma-delta T cell differentiation; ISO:RGD.
DR   GO; GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; ISO:RGD.
DR   GO; GO:0032733; P:positive regulation of interleukin-10 production; ISO:RGD.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISO:RGD.
DR   GO; GO:0032752; P:positive regulation of interleukin-3 production; ISO:RGD.
DR   GO; GO:0032753; P:positive regulation of interleukin-4 production; ISS:UniProtKB.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; ISO:RGD.
DR   GO; GO:0051712; P:positive regulation of killing of cells of another organism; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0032765; P:positive regulation of mast cell cytokine production; ISO:RGD.
DR   GO; GO:0043306; P:positive regulation of mast cell degranulation; IMP:RGD.
DR   GO; GO:0071639; P:positive regulation of monocyte chemotactic protein-1 production; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0031334; P:positive regulation of protein-containing complex assembly; ISO:RGD.
DR   GO; GO:0002092; P:positive regulation of receptor internalization; ISO:RGD.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; ISO:RGD.
DR   GO; GO:1904263; P:positive regulation of TORC1 signaling; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; ISO:RGD.
DR   GO; GO:0006606; P:protein import into nucleus; ISO:RGD.
DR   GO; GO:0031623; P:receptor internalization; ISS:UniProtKB.
DR   GO; GO:0090237; P:regulation of arachidonic acid secretion; ISS:UniProtKB.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; IDA:RGD.
DR   GO; GO:0043313; P:regulation of neutrophil degranulation; ISS:UniProtKB.
DR   GO; GO:0050764; P:regulation of phagocytosis; ISS:UniProtKB.
DR   GO; GO:0010543; P:regulation of platelet activation; ISS:UniProtKB.
DR   GO; GO:0090330; P:regulation of platelet aggregation; ISS:UniProtKB.
DR   GO; GO:0032928; P:regulation of superoxide anion generation; ISS:UniProtKB.
DR   GO; GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0001820; P:serotonin secretion; ISO:RGD.
DR   GO; GO:0002554; P:serotonin secretion by platelet; ISS:UniProtKB.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; ISO:RGD.
DR   CDD; cd05116; PTKc_Syk; 1.
DR   CDD; cd10401; SH2_C-SH2_Syk_like; 1.
DR   CDD; cd09938; SH2_N-SH2_Zap70_Syk_like; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 2.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR023420; Kinase_SYK/ZAP-70_inter-SH2_sf.
DR   InterPro; IPR050198; Non-receptor_tyrosine_kinases.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR035838; SYK/ZAP-70_N_SH2.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR012234; Tyr_kinase_non-rcpt_SYK/ZAP70.
DR   PANTHER; PTHR24418; TYROSINE-PROTEIN KINASE; 1.
DR   PANTHER; PTHR24418:SF231; TYROSINE-PROTEIN KINASE SYK; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00017; SH2; 2.
DR   PIRSF; PIRSF000604; TyrPK_SYK; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF55550; SH2 domain; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 2.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Alternative splicing; Angiogenesis; ATP-binding;
KW   Cell membrane; Cytoplasm; Immunity; Innate immunity; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat; SH2 domain;
KW   Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   CHAIN           1..629
FT                   /note="Tyrosine-protein kinase SYK"
FT                   /id="PRO_0000088167"
FT   DOMAIN          14..106
FT                   /note="SH2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          167..258
FT                   /note="SH2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          365..625
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          107..166
FT                   /note="Interdomain A"
FT                   /evidence="ECO:0000250"
FT   REGION          259..364
FT                   /note="Interdomain B"
FT                   /evidence="ECO:0000250"
FT   REGION          289..330
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        488
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         371..379
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         396
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         27
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         43
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         46
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         130
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         201
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         255
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         270
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48025"
FT   MOD_RES         289
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         290
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         311
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         317
FT                   /note="Phosphotyrosine; by LYN"
FT                   /evidence="ECO:0000269|PubMed:12077122"
FT   MOD_RES         339
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         342
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:12077122"
FT   MOD_RES         344
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         346
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:12077122"
FT   MOD_RES         358
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         373
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         378
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         478
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         501
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         519
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         520
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         524
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         540
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P48025"
FT   MOD_RES         573
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         576
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         623
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         624
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   MOD_RES         625
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P43405"
FT   VAR_SEQ         277..299
FT                   /note="Missing (in isoform SykA)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005011"
SQ   SEQUENCE   629 AA;  71529 MW;  81169A643EC6A6FE CRC64;
     MAGNAVDNAN HLTYFFGNIT REEAEDYLVQ GGMTDGLYLL RQSRNYLGGF ALSVAHNRKA
     HHYTIERELN GTYAISGGRA HASPADLCHY HSQEPEGLVC LLKKPFNRPP GVQPKTGPFE
     DLKENLIREY VKQTWNLQGQ ALEQAIISQK PQLEKLIATT AHEKMPWFHG NISRDESEQT
     VLIGSKTNGK FLIRARDNNG SFALCLLHEG KVLHYRIDRD KTGKLSIPEG KKFDTLWQLV
     EHYSYKPDGL LRVLTVPCQK IGVQMGHPGS SNAHPVTWSP GGIISRIKSY SFPKPGHKKP
     PPPQGSRPES TVSFNPYEPT GGAWGPDRGL QREALPMDTE VYESPYADPE EIRPKEVYLD
     RKLLTLEDNE LGSGNFGTVK KGYYQMKKVV KTVAVKILKN EANDPALKDE LLAEANVMQQ
     LDNPYIVRMI GICEAESWML VMEMAAWGPL NKYLQQNRHI KDKNIIELVH QVSMGMKYLE
     ESNFVHRDLA ARNVLLVTQH YAKISDFGLS KALRADENYY KAQTHGKWPV KWYAPECINY
     FKFSSKSDVW SFGVLMWEAF SYGQKPYRGM KGSEVTAMLE KGERMGCPPG CPREMYDLMF
     LCWTYDVENR PGFAAVELRL RNYYYDVVN
//
